PA
EL

Ember LifeSciences

Reusable smart shipping containers with real-time monitoring ensure safe, sustainable delivery of temp-sensitive medicines.

Visit Website

Known For

World's first self-refrigerated cloud-connected shipping box with real-time intervention

Key Differentiators

  • World's first self-refrigerated cloud-connected shipping box with real-time intervention
  • reusable design reduces waste by millions of lbs
  • patented temp control tech with 200+ patents, supports extreme temps incl. cryogenic.

Overview

Ember LifeSciences develops reusable, smart cold chain shipping containers using proprietary temperature control technology to transport temperature-sensitive pharmaceuticals, biologics, vaccines, and lab specimens. The flagship Ember Cube provides active refrigeration, real-time GPS/temperature monitoring via cloud dashboard, and sustainability benefits by replacing single-use packaging. Upcoming products include Ember Cube 2 (passive modular), Ultra-Cold Cube (-20°C to -60°C), and Cryogenic Shipper (below -150°C for cell/gene therapies).

Services & Capabilities

  • Ember Cube (self-refrigerated cloud-based shipping box, 2-8°C for 72+ hrs), Ember Cube 2 (passive modular with vacuum insulation & PCM packs), Ultra-Cold Cube (-20°C to -60°C), Cryogenic Shipper (LN2, below -150°C up to 12 days), cloud-based real-time tracking & alerts.

Competitive Position

  • World’s first self-refrigerated cloud-connected shipping box with real-time intervention
  • reusable design reduces waste by millions of lbs
  • patented temp control tech with 200+ patents, supports extreme temps incl. cryogenic.

Recent Developments

$16.5M Series A funding (Dec 2025) for Ember Cube 2 expansion & patient deployments ; USADA partnership for Olympic Trials sample transport (2024) ; sponsoring LogiPharma 2026 . No hits in specified sources (FiercePharma etc.).

Client & Partner Ecosystem

CVS Health, Chartwell, USADA; investors: Sea Court Capital, Cardinal Health, Carrier Ventures; Cardinal Health (investor/partner for Ember Cube dev); USADA (2024 Olympic Trials); CVS Health (early adopter per news)

Technology Platform

Ember temperature control platform (Ember Cube ecosystem)

Therapeutic Focus

broad/all (temperature-sensitive biologics, vaccines, pharma, cell & gene therapy)

Target Customers

pharmaceutical distributors, specialty pharmacies, infusion pharmacies, testing laboratories, pharma supply chain

Sources